| F7 |
F7: Coagulation factor VII precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.012 |
Evidence |
|
| HCK |
IPI00029769 |
STAT3 |
|
1.012 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
| CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
1.012 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
1.012 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.012 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
| GSN |
GSN: Gelsolin precursor |
SEC24C |
SEC24C, KIAA0079: Protein transport protein Sec24C |
1.012 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.012 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.012 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
1.012 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
CSK |
CSK: Tyrosine-protein kinase CSK |
1.012 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
FER |
FER, TYK3: Proto-oncogene tyrosine-protein kinase FER |
1.012 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
HGF |
HGF, HPTA: Hepatocyte growth factor precursor |
1.012 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
NCOA3 |
NCOA3, AIB1, RAC3, TRAM1: Nuclear receptor coactivator 3 |
1.012 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MLXIPL |
MLXIPL, MIO, WBSCR14: Williams-Beuren syndrome chromosome region 14 protein |
1.012 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TAL2 |
TAL2: T-cell acute lymphocytic leukemia protein 2 |
1.012 |
Evidence |
|
| MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
MAX |
MAX: Protein max |
1.012 |
Evidence |
|
| MMP1 |
MMP1, CLG: Interstitial collagenase precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.012 |
Evidence |
|
| TIMP1 |
TIMP1, CLGI, TIMP: Metalloproteinase inhibitor 1 precursor |
BMP1 |
IPI00009054 |
1.012 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
1.012 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
1.012 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
1.012 |
Evidence |
|
| PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINB1 |
SERPINB1, ELANH2, MNEI, PI2: Leukocyte elastase inhibitor |
1.012 |
Evidence |
|